Arctigenin Suppresses the Proliferation and Metastasis, and Induces Apoptosis and Cycle Arrest of Osteosarcoma Cells by inhibiting HMOX1 Expression


Citar

Texto integral

Resumo

Background: Osteosarcoma is the most common malignant bone tumor, with highly proliferative and metastatic properties. Previous studies have reported that arctigenin (Arc), a bioactive lignin compound, showed excellent anti-tumor activities in a variety of human cancers. However, its role in osteosarcoma has not been studied.

Objective: We aimed to investigate the anti-tumor effects of Arc on osteosarcoma cell proliferation, migration, invasion, apoptosis, and cell cycle.

Methods: Effects of Arc on osteosarcoma cell proliferation were detected by MTT and colony formation assay. Flow cytometry analysis was performed to assess the cell apoptosis and cycle arrest. Transwell assay was used to evaluate the capability of migration and invasion. qRT-PCR and Western blot were employed to determine the changes in mRNA and protein levels.

Results: Arc could significantly suppress the proliferation, colony formation, and induce cell apoptosis and S phase cycle arrest of MG63 and U-2 OS cells in a dose-dependent manner. In addition, we also observed an inhibitory effect of Arc treatment on osteosarcoma cell invasion, migration, and epithelial-mesenchymal transition (EMT). HMOX1, encoding enzyme heme oxygenase-1, was predicted to be a candidate target of Arc using STITCH. Arc treatment significantly reduced the mRNA and protein levels of HMOX1. Furthermore, overexpression of HMOX1 could partly reverse the inhibitory effects of Arc on osteosarcoma cell malignant phenotypes.

Conclusion: Our results suggest that Arc inhibits the proliferation, metastasis and promotes cell apoptosis and cycle arrest of osteosarcoma cells by downregulating HMOX1 expression.

Sobre autores

Guosong Xu

Department of Orthopedics, The First Hospital of Putian City

Email: info@benthamscience.net

Zhensen He

Department of Orthopedics, The First Hospital of Putian City

Email: info@benthamscience.net

Yinping Liu

Department of Orthopedics, The First Hospital of Putian City

Autor responsável pela correspondência
Email: info@benthamscience.net

Bibliografia

  1. Harrison, D.J.; Geller, D.S.; Gill, J.D.; Lewis, V.O.; Gorlick, R. Current and future therapeutic approaches for osteosarcoma. Expert Rev. Anticancer Ther., 2018, 18(1), 39-50. doi: 10.1080/14737140.2018.1413939 PMID: 29210294
  2. Gill, J.; Gorlick, R. Advancing therapy for osteosarcoma. Nat. Rev. Clin. Oncol., 2021, 18(10), 609-624. doi: 10.1038/s41571-021-00519-8 PMID: 34131316
  3. Shoaib, Z.; Fan, T.M.; Irudayaraj, J.M.K. Osteosarcoma mechanobiology and therapeutic targets. Br. J. Pharmacol., 2022, 179(2), 201-217. doi: 10.1111/bph.15713 PMID: 34679192
  4. Sheng, G.; Gao, Y.; Yang, Y.; Wu, H. Osteosarcoma and metastasis. Front. Oncol., 2021, 11, 780264. doi: 10.3389/fonc.2021.780264 PMID: 34956899
  5. Sun, W.J.; Sha, Z.F.; Gao, H. Determination of arctiin and arctigenin in fructus arctii by reverse-phase HPLC. Yao Xue Xue Bao, 1992, 27(7), 549-551. PMID: 1442089
  6. Zhao, F.; Wang, L.; Liu, K. In vitro anti-inflammatory effects of arctigenin, a lignan from Arctium lappa L., through inhibition on iNOS pathway. J. Ethnopharmacol., 2009, 122(3), 457-462. doi: 10.1016/j.jep.2009.01.038 PMID: 19429312
  7. Xu, X.; Piao, H.N.; Aosai, F.; Zeng, X.Y.; Cheng, J.H.; Cui, Y.X.; Li, J.; Ma, J.; Piao, H.R.; Jin, X.; Piao, L.X. Arctigenin protects against depression by inhibiting microglial activation and neuroinflammation via HMGB1/TLR4/NF-κB and TNF-α/TNFR1/NF-κB pathways. Br. J. Pharmacol., 2020, 177(22), 5224-5245. doi: 10.1111/bph.15261 PMID: 32964428
  8. Shen, Y.F.; Liu, L.; Chen, W.C.; Hu, Y.; Zhu, B.; Wang, G.X. Evaluation on the antiviral activity of arctigenin against spring viraemia of carp virus. Aquaculture, 2018, 483, 252-262. doi: 10.1016/j.aquaculture.2017.09.001 PMID: 32287458
  9. He, Y.; Fan, Q.; Cai, T.; Huang, W.; Xie, X.; Wen, Y.; Shi, Z. Molecular mechanisms of the action of arctigenin in cancer. Biomed. Pharmacother., 2018, 108, 403-407. doi: 10.1016/j.biopha.2018.08.158 PMID: 30236849
  10. Luo, W.; Wang, F.; Luo, H.; Liu, H. Arctigenin inhibits human breast cancer cell proliferation, migratory and invasive abilities and epithelial to mesenchymal transition by targeting 4EBP1. Exp. Ther. Med., 2021, 21(6), 547. doi: 10.3892/etm.2021.9979 PMID: 33850519
  11. Wang, Y.; Lina, L.; Xu, L.; Yang, Z.; Qian, Z.; Zhou, J.; Suoni, L. Arctigenin enhances the sensitivity of cisplatin resistant colorectal cancer cell by activating autophagy. Biochem. Biophys. Res. Commun., 2019, 520(1), 20-26. doi: 10.1016/j.bbrc.2019.09.086 PMID: 31564411
  12. Shi, H.; Zhao, L.; Guo, X.; Fang, R.; Zhang, H.; Dong, G.; Fu, J.; Yan, F.; Zhang, J.; Ning, Z.; Ma, Q.; Li, Z.; Li, C.; Dai, J.; Si, C.; Xiong, H. Arctigenin attenuates breast cancer progression through decreasing GM-CSF/TSLP/STAT3/β-Catenin signaling. Int. J. Mol. Sci., 2020, 21(17), 6357. doi: 10.3390/ijms21176357 PMID: 32887217
  13. Yang, S.; Ma, J.; Xiao, J.; Lv, X.; Li, X.; Yang, H.; Liu, Y.; Feng, S.; Zhang, Y. Arctigenin anti-tumor activity in bladder cancer T24 cell line through induction of cell-cycle arrest and apoptosis. Anat. Rec. , 2012, 295(8), 1260-1266. doi: 10.1002/ar.22497 PMID: 22619087
  14. Sun, B.; Cai, E.; Zhao, Y.; Wang, Y.; Yang, L.; Wang, J.Y. Arctigenin triggers apoptosis and autophagy via PI3K/Akt/mTOR Inhibition in PC-3M Cells. Chem. Pharm. Bull., 2021, 69(5), 472-480. doi: 10.1248/cpb.c21-00021 PMID: 33627540
  15. Li, H.; Yang, C.; Lan, M.; Liao, X.; Tang, Z. Arctigenin promotes bone formation involving PI3K/Akt/PPARγ signaling pathway. Chem. Biol. Drug Des., 2020, 95(4), 451-459. doi: 10.1111/cbdd.13659 PMID: 31883507
  16. Yamashita, T.; Uehara, S.; Udagawa, N.; Li, F.; Kadota, S.; Esumi, H.; Kobayashi, Y.; Takahashi, N. Arctigenin inhibits osteoclast differentiation and function by suppressing both calcineurin-dependent and osteoblastic cell-dependent NFATc1 pathways. PLoS One, 2014, 9(1), e85878. doi: 10.1371/journal.pone.0085878 PMID: 24465763
  17. Kim, A.R.; Kim, H.S.; Lee, J.M.; Choi, J.H.; Kim, S.N.; Kim, D.K.; Kim, J.H.; Mun, S.H.; Kim, J.W.; Jeon, H.S.; Kim, Y.M.; Choi, W.S. Arctigenin suppresses receptor activator of nuclear factor κB ligand (RANKL)-mediated osteoclast differentiation in bone marrow-derived macrophages. Eur. J. Pharmacol., 2012, 682(1-3), 29-36. doi: 10.1016/j.ejphar.2012.02.026 PMID: 22387094
  18. Ahmad, Z.; Salim, M.; Maines, M.D. Human biliverdin reductase is a leucine zipper-like DNA-binding protein and functions in transcriptional activation of heme oxygenase-1 by oxidative stress. J. Biol. Chem., 2002, 277(11), 9226-9232. doi: 10.1074/jbc.M108239200 PMID: 11773068
  19. Kharb, S.; Halder, M.; Kundu, Z.S. Heme oxygenase-1 in osteosarcoma. J. Cancer Res. Ther., 2020, 16(4), 874-877. doi: 10.4103/jcrt.JCRT_419_17 PMID: 32930133
  20. Lin, H.; Chen, X.; Zhang, C.; Yang, T.; Deng, Z.; Song, Y.; Huang, L.; Li, F.; Li, Q.; Lin, S.; Jin, D. EF24 induces ferroptosis in osteosarcoma cells through HMOX1. Biomed. Pharmacother., 2021, 136, 111202. doi: 10.1016/j.biopha.2020.111202 PMID: 33453607
  21. Zhong, L.; Wang, Y.; Li, W.; Gu, J.; Li, X.; Wang, X.; Yue, Z.; Mu, Y.; Bai, J.; Li, R.; Zhang, H. Heme oxygenase-1 silencing increases the sensitivity of human osteosarcoma MG63 cells to arsenic trioxide. Mol. Cell. Biochem., 2014, 392(1-2), 135-144. doi: 10.1007/s11010-014-2027-1 PMID: 24676542
  22. Avila-Carrasco, L.; Majano, P.; Sánchez-Toméro, J.A.; Selgas, R.; López-Cabrera, M.; Aguilera, A.; González Mateo, G. Natural plants compounds as modulators of epithelial-to-mesenchymal transition. Front. Pharmacol., 2019, 10, 715. doi: 10.3389/fphar.2019.00715 PMID: 31417401
  23. Babaei, G.; Aziz, S.G.G.; Jaghi, N.Z.Z. EMT, cancer stem cells and autophagy; The three main axes of metastasis. Biomed. Pharmacother., 2021, 133, 110909. doi: 10.1016/j.biopha.2020.110909 PMID: 33227701
  24. Xu, Z.; Zhang, Y.; Dai, H.; Han, B. Epithelial–mesenchymal transition-mediated tumor therapeutic resistance. Molecules, 2022, 27(15), 4750. doi: 10.3390/molecules27154750 PMID: 35897925
  25. Yang, C.; Tian, Y.; Zhao, F.; Chen, Z.; Su, P.; Li, Y.; Qian, A. Bone microenvironment and osteosarcoma metastasis. Int. J. Mol. Sci., 2020, 21(19), 6985. doi: 10.3390/ijms21196985 PMID: 32977425
  26. Yang, Z.; Li, X.; Yang, Y.; He, Z.; Qu, X.; Zhang, Y. Long noncoding RNAs in the progression, metastasis, and prognosis of osteosarcoma. Cell Death Dis., 2016, 7(9), e2389. doi: 10.1038/cddis.2016.272 PMID: 27685633
  27. Hemmati, M.; Yousefi, B.; Bahar, A.; Eslami, M. Importance of heme oxygenase-1 in gastrointestinal cancers: Functions, inductions, regulations, and signaling. J. Gastrointest. Cancer, 2021, 52(2), 454-461. doi: 10.1007/s12029-021-00587-0 PMID: 33484436
  28. Krukowska, K.; Magierowski, M. Carbon monoxide (CO)/heme oxygenase (HO)-1 in gastrointestinal tumors pathophysiology and pharmacology - possible anti- and pro-cancer activities. Biochem. Pharmacol., 2022, 201, 115058. doi: 10.1016/j.bcp.2022.115058 PMID: 35490732
  29. Sferrazzo, G.; Di Rosa, M.; Barone, E.; Li Volti, G.; Musso, N.; Tibullo, D.; Barbagallo, I. Heme oxygenase-1 in central nervous system malignancies. J. Clin. Med., 2020, 9(5), 1562. doi: 10.3390/jcm9051562 PMID: 32455831
  30. Zhao, Z.; Xu, Y.; Lu, J.; Xue, J.; Liu, P. High expression of HO-1 predicts poor prognosis of ovarian cancer patients and promotes proliferation and aggressiveness of ovarian cancer cells. Clin. Transl. Oncol., 2018, 20(4), 491-499. doi: 10.1007/s12094-017-1738-7 PMID: 28808929
  31. Andrés, N.C.; Fermento, M.E.; Gandini, N.A.; Romero, A.L.; Ferro, A.; Donna, L.G.; Curino, A.C.; Facchinetti, M.M. Heme oxygenase-1 has antitumoral effects in colorectal cancer: Involvement of p53. Exp. Mol. Pathol., 2014, 97(3), 321-331. doi: 10.1016/j.yexmp.2014.09.012 PMID: 25236576
  32. Zou, C.; Zou, C.; Cheng, W.; Li, Q.; Han, Z.; Wang, X.; Jin, J.; Zou, J.; Liu, Z.; Zhou, Z.; Zhao, W.; Du, Z. Heme oxygenase-1 retards hepatocellular carcinoma progression through the microRNA pathway. Oncol. Rep., 2016, 36(5), 2715-2722. doi: 10.3892/or.2016.5056 PMID: 27571925
  33. Gandini, N.A.; Alonso, E.N.; Fermento, M.E.; Mascaró, M.; Abba, M.C.; Coló, G.P.; Arévalo, J.; Ferronato, M.J.; Guevara, J.A.; Núñez, M.; Pichel, P.; Curino, A.C.; Facchinetti, M.M. Heme oxygenase-1 has an antitumor role in breast cancer. . Antioxid. Redox Signal., , 2019, 30(18), ars.2018.7554.. doi: 10.1089/ars.2018.7554 PMID: 30484334
  34. Jiang, Y.; Liu, J.; Hong, W.; Fei, X.; Liu, R. Arctigenin inhibits glioblastoma proliferation through the AKT/mTOR pathway and induces autophagy. BioMed Res. Int., 2020, 2020, 1-13. doi: 10.1155/2020/3542613 PMID: 33015162
  35. Li, Q.C.; Liang, Y.; Tian, Y.; Hu, G.R. Arctigenin induces apoptosis in colon cancer cells through ROS/p38MAPK pathway. J. BUON, 2016, 21(1), 87-94. PMID: 27061535
  36. Lee, M.G.; Lee, K.S.; Nam, K.S. Anti metastatic effects of arctigenin are regulated by MAPK/AP 1 signaling in 4T 1 mouse breast cancer cells. Mol. Med. Rep., 2020, 21(3), 1374-1382. doi: 10.3892/mmr.2020.10937 PMID: 32016480
  37. Lu, Z.; Chang, L.; Zhou, H.; Liu, X.; Li, Y.; Mi, T.; Tong, D. Arctigenin attenuates tumor metastasis through inhibiting epithelial–mesenchymal transition in hepatocellular carcinoma via suppressing GSK3β-Dependent Wnt/β-Catenin signaling pathway in vivo and in vitro. Front. Pharmacol., 2019, 10, 937. doi: 10.3389/fphar.2019.00937 PMID: 31555129

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML
Baixar

Declaração de direitos autorais © Bentham Science Publishers, 2023